Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

Recruiting NCT07221851

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

Conditions: Turner Syndrome, Short Stature Homeobox Gene Mutation, Idiopathic Short Stature, Small for Gestational Age at Delivery

Sex: All

Ages: 2 Years – 17 Years

Healthy volunteers: No

Phase: PHASE3

Enrollment: 186

Sponsor: Ascendis Pharma A/S

Location: Ascendis Pharma Investigational Site Palo Alto California

Summary

This basket trial will enroll prepubertal children and adolescents with clinically diagnosed and genetically confirmed (if applicable) TS, SHOX-D, SGA, or ISS between ages of ≥2 and \

Eligibility Criteria

Inclusion Criteria: 1. Chronological age between ≥2 and \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07221851). StuddyBuddy aggregates publicly available trial information.